Comments

Roivant Sciences Stock Price, Quotes and Forecasts

Q: What sector and industry does Roivant Sciences (ROIV) operate in?

Roivant Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ROIVNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$11.08

-0.15-1.34%

At close: -

$11.03

-0.05-0.45%

After Hours: 4:18 PM EDT

Roivant Sciences (ROIV) Forecast

News Earnings Roivant Sciences (ROIV) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Roivant Sciences Stock Price, Quotes and Forecasts | NASDAQ:ROIV | Benzinga

Explore Roivant Sciences stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ROIV.

Open	$11.32
Close	$11.08
Volume / Avg.	3.59M / 6.59M
Day Range	$10.99 - $11.33
52 Wk Range	8.73 - 13.06
Market Cap	$7.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	9.88%
Days to Cover	8.53

Recent News

Stocks Edge Higher After Court Stifles Trump Tariffs, Nvidia Rallies To 3-Month Highs, Bitcoin Dips Below $107K: What's Driving Markets Thursday?

Wall Street hovered slightly higher by midday Thursday, giving up a chunk of strong overnight gains in futures markets that were triggered by a federal court ruling suspending a large portion of President Donald Trump’s tari

Piero Cingari

Immunovant Ditches Seeking FDA Approval For Batoclimab For Two Autoimmune Disorders Despite Positive Phase 3 Data

Immunovant's batoclimab showed positive Phase 3 results in MG but won't be pursued for approval as the company shifts focus to its lead asset, IMVT-1402.

Vandana Singh

Tech Stocks Surge, Steelmakers Jump On Trump's 25% Tariffs, Copper Hits 9-Month Highs: What's Driving Markets Monday?

Wall Street bounced back on Monday, recovering from Friday's robust decline fueled by tariff concerns, as investors remained focused on strong earnings from the fourth-quarter reporting season while awaiting further clarity on trade policie

Piero Cingari

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$11.32
Close	$11.08
Volume / Avg.	3.59M / 6.59M
Day Range	$10.99 - $11.33
52 Wk Range	8.73 - 13.06
Market Cap	$7.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	9.88%
Days to Cover	8.53

About Roivant Sciences Ltd

Sector

Health Care

Industry

Biotechnology

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the deli...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Roivant Sciences (ROIV) stock?

You can purchase shares of Roivant Sciences (NASDAQ:ROIV) through any online brokerage.

View our list of the best stock brokerages

Who are Roivant Sciences (ROIV) competitors?

Other companies in Roivant Sciences’s space includes: BeOne Medicines (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Amgen (NASDAQ:AMGN) and United Therapeutics (NASDAQ:UTHR).

What is the forecast, or price target, for Roivant Sciences (ROIV) stock?

Roivant Sciences has a consensus price target of $16.41.

What is the current price for Roivant Sciences (ROIV)?

The stock price for Roivant Sciences (NASDAQ: ROIV) is $11.03 last updated June 9, 2025 at 4:18 PM EDT.

Does Roivant Sciences (ROIV) pay a dividend?

There are no upcoming dividends for Roivant Sciences.

When is Roivant Sciences (NASDAQ:ROIV) reporting earnings?

Roivant Sciences’s Q1 earnings are confirmed for Thursday, August 7, 2025.

Is Roivant Sciences (ROIV) going to split?

There is no upcoming split for Roivant Sciences.

What sector and industry does Roivant Sciences (ROIV) operate in?

Roivant Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.